Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2013 Jun;79(11):3336–3345. doi: 10.1128/AEM.00071-13

New Insight into the Cleavage Reaction of Nostoc sp. Strain PCC 7120 Carotenoid Cleavage Dioxygenase in Natural and Nonnatural Carotenoids

Jinsol Heo 1, Se Hyeuk Kim 1, Pyung Cheon Lee 1,
PMCID: PMC3648047  PMID: 23524669

Abstract

Carotenoid cleavage dioxygenases (CCDs) are enzymes that catalyze the oxidative cleavage of carotenoids at a specific double bond to generate apocarotenoids. In this study, we investigated the activity and substrate preferences of NSC3, a CCD of Nostoc sp. strain PCC 7120, in vivo and in vitro using natural and nonnatural carotenoid structures. NSC3 cleaved β-apo-8′-carotenal at 3 positions, C-13Inline graphicC-14, C-15Inline graphicC-15′, and C-13′Inline graphicC-14′, revealing a unique cleavage pattern. NSC3 cleaves the natural structure of carotenoids 4,4′-diaponeurosporene, 4,4′-diaponeurosporen-4′-al, 4,4′-diaponeurosporen-4′-oic acid, 4,4′-diapotorulene, and 4,4′-diapotorulen-4′-al to generate novel cleavage products (apo-14′-diaponeurosporenal, apo-13′-diaponeurosporenal, apo-10′-diaponeurosporenal, apo-14′-diapotorulenal, and apo-10′-diapotorulenal, respectively). The study of carotenoids with natural or nonnatural structures produced by using synthetic modules could provide information valuable for understanding the cleavage reactions or substrate preferences of other CCDs in vivo and in vitro.

INTRODUCTION

Carotenoids belong to a class of isoprenoid derivatives found in many organisms, including photosynthetic and nonphotosynthetic bacteria (1). They have diverse biological functions, such as involvement in coloration, antioxidation activity, light harvesting, energy transfer, membrane fluidity regulation, and the quenching of singlet oxygen or peroxy radicals (24). To date, more than 700 carotenoids have been identified and classified as C30, C40, and C50 carotenoids, depending on the number of carbons in their carotene backbones (5).

Animals do not biosynthesize carotenoids de novo and thus obtain carotenoids mainly from dietary fruits or vegetables. Most carotenoids consumed (including xanthines) are oxidatively cleaved by carotenoid cleavage dioxygenases (CCDs), and the resulting cleavage compounds (for example, retinal) function as transcriptional system activators or cellular components (6).

CCDs are enzymes that catalyze the oxidative cleavage of carotenoids; they are found in animals, plants, photosynthetic bacteria, algae, and cyanobacteria. The cleavage of carotenoids results in the formation of structurally diverse apocarotenals that carry out biological functions, including their general roles as antioxidants, agents of volatile aromas and flavors, provitamin A, and regulators of retinoids (7). The physiological functions of apocarotenoids in plants as precursors of phytohormones, such as abscisic acid and strigolactone, have been reported recently (810). For example, strigolactone, which triggers seed germination in plants, is derived from C18 β-apo-13-carotenone, which is produced when CCD8 cleaves C27 β-apo-10′-carotenal (9). The elucidation of novel aspects of potential health-promoting mechanisms has drawn increasing attention to the effects of diverse apocarotenoid structures (6). Bacterial CCDs, except for those of cyanobacteria such as Synechocystis and Nostoc, as well as Anabaena spp., have not been well studied yet. Recently, CCDs have been identified in several proteobacteria: Novosphingobium aromaticivorans, Sphingopyxis alaskensis, and Plesiocystis pacifica (11, 12). Mycobacterium tuberculosis contains CCDs in its genome, although it cannot biosynthesize carotenoids (13).

In Nostoc sp. strain PCC 7120, a representative carotenogenic cyanobacterium, retinal was first noted as a chromophore of the light-activated photoreceptor rhodopsin (14). Three CCDs, NSC1 (Nostoc CCD [NosCCD]; GenBank accession no. NP_485149), NSC2 (Nostoc apocarotenal cleavage oxygenase [NosACO]; GenBank accession no. NP_488324), and NSC3 (Nostoc dioxygenase 2 [NosDiox2]; GenBank accession no. NP_488935) (Fig. 1A) have been identified in Nostoc sp. PCC 7120 (1517). Soluble NSC1, which is encoded by all1106, cleaves in vitro C-9Inline graphicC-10 and C-9′Inline graphicC-10′ double bonds in bicyclic carotenoids, including β-carotene, and C-9Inline graphicC-10 and C-7′Inline graphicC-8′ double bonds in monocyclic carotenoids, including myxoxanthophyll. NSC2, which is encoded by all4284, cleaves monocyclic or acyclic (linear) carotenoids at C-15Inline graphicC-15′ double bonds to generate retinal in vitro but barely cleaves β-carotene in vivo. NSC3, which is encoded by all4895, cleaves β-apo-8′-carotenal at C-9Inline graphicC-10 double bonds in vitro, but no detailed biochemical activity of NSC3 in vivo or in vitro has been reported (16, 17). Furthermore, the preferred in vivo and in vitro substrates have not been determined, owing mainly to the unavailability of carotenoids with various structures.

Fig 1.

Fig 1

Selected cleavage patterns of β-carotene and β-apo-8′-carotenal. (A) Carotenoid cleavage reactions for various cleavage enzymes. CCD, carotenoid cleavage dioxygenase; ACO, apocarotenal cleavage oxygenase. (B) Characterized cleavage sites on β-apo-8′-carotenal and resulting cleavage products catalyzed by NSC3 in this study.

Synthetic biological approaches have been widely used for the redesign and reconstruction of biosynthetic pathways in heterologous hosts (18, 19). The functional, modular expression of redesigned pathway enzymes can improve the productivity and yield of target molecules (20). Moreover, the modular expression of a pathway enzyme can be used as a tool for diversifying the structures of natural and nonnatural molecules, such as carotenoids, by using combinatorial biosynthesis in heterologous hosts (21). Therefore, carotenoids with natural or nonnatural structures, including natural or nonnatural C30 carotenoids, can provide new insight into the cleavage reactions or substrate preferences of CCDs, including NSC3, in vivo and in vitro.

Here we describe the activity and substrate preferences of NSC3 in vitro and in vivo with natural and nonnatural carotenoid structures generated using synthetic carotenoid modules in Escherichia coli. We reveal that NSC3 has unique cleavage activity (C-13Inline graphicC-14, C-15Inline graphicC-15′, and C-13′Inline graphicC-14′) with respect to β-apo-8′-carotenal in vitro (Fig. 1B), as well as with other carotenoid structures in vivo and in vitro. In addition, we found that NSC3 uses natural (4,4′-diaponeurosporene, 4,4′-diaponeurosporen-4′-al, and 4,4′-diaponeurosporen-4′-oic acid) and nonnatural (4,4′-diapotorulene and 4,4′-diapotorulen-4′-al) C30 carotenoids (not apocarotenoids) as substrates to generate structurally novel cleavage products. These novel apocarotenal structures might be bioactive candidates of biotechnological significance.

MATERIALS AND METHODS

Cloning and culture conditions.

We amplified all4895, which encodes NSC3, from the genomic DNA of Nostoc sp. PCC 7120 by using PCR with a 5′ primer that contained an XbaI restriction enzyme site followed by an optimized Shine-Dalgarno sequence (underlined) and a start codon (boldface) (5′-AGGAGGATTACAAAATG-3′) and a 3′ primer that contained an EcoRI restriction enzyme site at its 5′ end. The PCR product was purified with a PCR product purification kit (Macrogen, South Korea). It was then digested using XbaI and EcoRI (New England BioLabs) and was ligated into the corresponding restriction sites of plasmid pUCM (22). For the overexpression of His6-tagged NSC3, the gene that encodes NSC3 was subcloned into the NdeI and XhoI sites of vector pET21a by using gene-specific primers that contained the corresponding restriction sites. For in vivo cleavage reaction studies, NSC3 was subcloned into the EcoRI and BamHI sites of pBBR1MCS-2, which can coexist with a plasmid that encodes carotenogenic gene modules. All of the cloning and in vivo analyses were carried out in E. coli strain JM109. Escherichia coli cultures were grown at 30°C in Luria-Bertani (LB) medium supplemented with an appropriate selective antibiotic (ampicillin [100 μg/ml], chloramphenicol [50 μg/ml], or kanamycin [30 μg/ml]) as needed. All of the plasmids and strains used in this study are listed in Table 1.

Table 1.

Strains and plasmids used in this study

Strain or plasmid Relevant properties Source or reference
Strains
    Nostoc sp. PCC 7120 C40 carotenoid pathway and rhodopsin; also known as Anabaena sp. PCC 7120 UTEX 2576
    Escherichia coli
        SURE endA1 glnV44 thi-1 gyrA96 relA1 lac recB recJ sbcC umuC::Tn5 uvrC e14 Δ(mcrCB-hsdSMR-mrr)171 F′[proAB+ lacIqlacZΔM15 Tn10] Stratagene
        JM109 endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ Δ(lac-proAB) e14 [F′ traD36 proAB+ lacIqlacZΔM15] hsdR17(rK mK+) New England BioLabs
        BL21(DE3) F ompT gal dcm lon hsdSB(rB mB) λ(DE3 [lacI lacUV5-T7 gene 1 ind1 Sam7 nin5])
Plasmids
    pUCM Cloning vector modified from pUC19; constitutive lac promoter; Apr 22
    pBBR1MCS-2 Cloning vector; SC101 origin; inducible lac promoter; Kmr 23
    pGro7 Chaperone plasmid inducibly expressing groES-groEL; araB promoter; Cmr TaKaRa
    pKJE7 Chaperone plasmid inducibly expressing dnaK-dnaJ-grpE; araB promoter; Cmr TaKaRa
    pUCM-NSC3 Constitutively expressed all4895 gene of Nostoc sp. PCC 7120 This study
    pBBR-NSC3 Inducibly expressed all4895 gene of Nostoc sp. PCC 7120 This study
    pET21-NSC3 Inducibly expressed His6-tagged all4895 gene of Nostoc sp. PCC 7120 This study
    pUCM-YtBL Constitutively expressed crtYcYdt gene of Brevibacterium linens Unpublished
    pUCM-aldHSA Constitutively expressed aldehyde dehydrogenase gene of Staphylococcus aureus 19
    pBBR-aldHSA Inducibly expressed aldehyde dehydrogenase gene of S. aureus 19
    pACM-MSA-NSA Constitutively expressed crtM and crtN genes of S. aureus on pACYC184 19
    pACM-MSA-NSA-PSA Constitutively expressed crtM, crtN, and crtP genes of S. aureus 19
    pACM-MSA-NySA-YtBL Constitutively expressed crtM, crtNy, and crtYcYdt genes of S. aureus and B. linens Unpublished
    pACM-EPAG-BPAG-IPAG Constitutively expressed crtE, crtB, and crtI genes from Pantoea agglomerans to produce lycopene 24
    pACM-EPAG-BPAG-IPAG-YPAG Constitutively expressed crtE, crtB, crtI, and crtY genes from P. agglomerans to produce β-carotene 24
    pACM-EPAG-BPAG-IPAG-YPAG-ZPAG Constitutively expressed crtE, crtB, crtI, crtY, and crtZ genes from P. agglomerans to produce zeaxanthin 24
    pAC-E-B-I14 Constitutively expressed crtE, crtB, and crtI14 genes of Pantoea ananatis 25
    pAC-E-B-I14-Y2 Constitutively expressed crtE, crtB, crtI14, and crtY2 genes of P. ananatis 26

Expression and purification of NCS3.

Escherichia coli BL21(DE3) was used to express and purify recombinant His6-tagged NSC3. To increase the expression of soluble NSC3, we cotransformed the pET21-NSC3 plasmid with a chaperone plasmid (pGro7 or pKJE7) carrying groES-groEL or dnaK-dnaJ-grpE, respectively (TaKaRa). The cotransformants were grown in 500 ml LB medium in a 2-liter flask containing 100 μg/ml ampicillin at 30°C with shaking at 210 rpm. When the absorbance of a culture reached 0.6 at 600 nm, 1 mM isopropyl β-d-thiogalactopyranoside and 0.5 mg/ml l-arabinose were added to induce the expression of the NSC3 and chaperone proteins. After induction, the culture was incubated at 18°C for another 16 h. After centrifugation (4,000 rpm, 30 min, and 4°C), the cell pellets were washed twice with 1× phosphate-buffered saline (PBS) buffer and were then resuspended in a phosphate buffer that contained 50 mM Na2PO4 at pH 7.0. Resuspended cells were sonicated on ice (20% power with pulsing [5 s on and 10 s off] for 5 min), and the cell debris was removed via centrifugation at 13,000 rpm for 30 min at 4°C.

The supernatant was concentrated using a Vivaspin 20 centrifugal filter (molecular weight cutoff, 30,000; Sartorius) and was applied to a HisTrap HP affinity chromatography column (GE Healthcare, Munich, Germany) equilibrated with 20 mM phosphate buffer (pH 8.0) containing 500 mM NaCl. The column was washed extensively with the same buffer, and the bound protein was eluted with a linear gradient between 20 and 500 mM imidazole (Sigma) at a flow rate of 1 ml/min. The purification step involving chromatography was performed using an ÄKTA fast protein liquid chromatography (FPLC) system (GE Amersham-Pharmacia). The fractions containing the recombinant protein were immediately pooled, concentrated in a Vivaspin 20 centrifugal filter (Sartorius), desalted with a PD10 desalting column (Amersham), and finally concentrated in 50 mM sodium phosphate buffer (pH 7.0). The proteins were quantified by the Bradford method, and homogeneity was confirmed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using Coomassie brilliant blue staining. The purified His6-tagged NSC3 was concentrated to ∼2 mg/ml.

In vitro assays.

In vitro reactions were performed using 5 μg purified NSC3 in a 300-μl reaction mixture consisting of 50 mM phosphate buffer (pH 7.0), 300 mM NaCl, 0.5 mM FeSO4, and 10 mM dithiothreitol. A carotenoid substrate including β-apo-8′-carotenal was dissolved in tert-methylethyl ester containing Tween 40 (final concentration, 0.3% [vol/vol]) to form detergent micelles, and the solution was sonicated for 30 min using an ultrasonicator (Branson). The solvent was evaporated using an EZ-2 Plus centrifugal evaporator (Genevac, Gardiner, NY), and then the reaction buffer was added. The resulting mixture was used as a substrate solution. To examine the effect of pH on the activity of NSC3, we varied the pH between 5.0 and 9.0 using 50 mM sodium acetate buffer (pH 5.0), 50 mM sodium phosphate buffer (pH 6.0, 7.0, and 8.0), and 50 mM glycine-NaOH buffer (pH 9.0). Then 50 μM β-apo-8′-carotenal and 5 μg enzyme were used for reactions at 30°C for 30 min. The relative activity of NSC3 was monitored in 50 mM sodium phosphate buffer (pH 7.0) for 30 min at various temperatures between 15°C and 45°C.

Enzyme kinetic analysis.

Initial measurements were carried out at 30°C using a UV spectrophotometer (SpectraMax Plus 384; Molecular Devices). Retinal and β-apo-8′-carotenal were quantified by peak integration using high-performance liquid chromatography (HPLC) analysis with known amounts of standard materials. To determine the kinetic values, we varied the concentration of β-apo-8′-carotenal between 20 and 100 μM, with the purified NSC3 concentration fixed at 5 μg. These enzymatic reactions were performed at 30°C for 30 min for each substrate concentration. The reactions were terminated by the addition of 300 μl chloroform. Subsequently, the samples were centrifuged at 13,200 rpm for 1 min, and the chloroform phase was collected. The treated samples were analyzed by HPLC using a Zorbax Eclipse XDB C18 column (inner diameter, 4.6 mm; length, 150 mm; particle size, 5 μm; Agilent Technologies, Santa Clara, CA). Conversion was measured photometrically for the corresponding substrate and product absorption maxima. Plotted data were fit to a Michaelis-Menten curve using SigmaPlot, version 12.0. Experiments were triplicated to ensure reproducibility.

In vivo analysis of carotenoid cleavage activity.

For in vivo analysis, a synthetic module that expressed a C30 or C40 carotenoid (Table 2) and pUCM-NSC3 were cotransformed into E. coli JM109. As a negative control, an empty vector (pUCM) was transformed into E. coli JM109 expressing a synthetic carotenogenic module. More than 3 colonies of each E. coli transformant were cultivated overnight at 37°C in 4 ml LB medium supplemented with the appropriate antibiotics. The cultured cells were transferred to 100 ml Terrific broth medium and were further cultivated at 30°C for 24 h at 250 rpm. The cells were harvested by centrifugation (at 4°C and 4,000 rpm for 20 min), and their pigments were extracted repeatedly with a total volume of 10 ml acetone until the pigments were visibly removed. After centrifugation (at 4°C and 4,000 rpm), the colored supernatants were pooled and reextracted with an equal volume of hexane after the addition of an equal volume of deionized distilled water. The color fractions were then dried under nitrogen gas and were resuspended with 0.2 ml ethyl acetate. After centrifugation (at 13,000 rpm and 20 min), the extracts were analyzed by liquid chromatography-mass spectroscopy (LC-MS).

Table 2.

Plasmids used to supply carotenoids with various structures in vivo

Pathway Plasmid Genes expresseda Major carotenoid(s) Reference
C30 pAC-MSA-NSA crtM, crtN 4,4′-Diaponeurosporene 19
pAC-MSA-NySA-YtBL crtM, crtNy, crtYcYdt 4,4′-Diapotorulene, 4,4′-diaponeurosporene Unpublished
pAC-MSA-NSA-PSA crtM, crtN, crtP 4,4′-Diaponeurosporen-4′-al, 4,4′-diapolycopene-4,4′-dial 19
pAC-MSA-NSA-PSA + pUCM-YtBL crtM, crtN, crtP, crtYcYdt 4,4′-Diapotorulen-4′-al, 4,4′-diaponeurosporen-4′-al Unpublished
pAC-MSA-NSA-PSA + pBBR-aldHSA crtM, crtN, crtP, aldH 4.4′-Diaponeurosporen-4′-oic acid, 4,4′-diaponeurosporen-4′-al 19
C40 pAC-EPA-BPA-IPA crtE, crtB, crtI Lycopene 24
pAC-EPA-BPA-IPA-YPA crtE, crtB, crtI, crtY β-Carotene 24
pAC-EPA-BPA-IPA-YPA-ZPA crtE, crtB, crtI, crtY, crtZ Zeaxanthin 24
pAC-E-B-I14 crtE, crtB, crtI14 3,4,3′,4′-Tetradehydrolycopene 25
pAC-E-B-I14-Y2 crtE, crtB, crtI14, crtY2 Torulene 26
a

Here crtP encodes 4,4-diaponeurosporene oxidase in Staphylococcus aureus, not phytoene desaturase (pds or crtP) in cyanobacteria, algae, and plants.

Production and purification of carotenoids.

For the production of carotenoids, recombinant E. coli SURE or JM109 cells harboring a synthetic module expressing carotenoids were cultivated in 1 liter Terrific broth medium supplemented with the appropriate selective antibiotics (chloramphenicol at 50 μg/ml or kanamycin at 30 μg/ml) for 48 h at 30°C and 250 rpm. The cells were harvested via centrifugation (at 4°C and 8,000 rpm for 20 min), transferred to a glass tube, and suspended in 15 ml acetone. Extraction was carried out until the visible pigments were removed. In order to dehydrate the acetone extracts, they were all passed through sodium sulfate (anhydrous; Bio Basic). They were then subjected to silica gel chromatography and were eluted with solvent systems of hexane-ethyl acetate (9:1, vol/vol) or hexane-acetone (9:1, vol/vol) depending on the polarity of the carotenoid. The color fractions were then dried under nitrogen gas. Purified carotenoid samples were stored at −80°C until use.

HPLC and LC-MS analysis.

Aliquots (10 to 20 μl) of the extracts from the in vitro or in vivo assays were applied to a Zorbax Eclipse XDB C18 column (inner diameter, 4.6 mm; length, 150 mm; particle size, 5 μm; Agilent Technologies) and were eluted with the following solvent systems by using an Agilent 1200 HPLC system equipped with a photodiode array detector: solvent A, acetonitrile-methanol (MeOH)-isopropyl alcohol (80:15:5, vol/vol/vol); solvent B, MeOH-water (70:30, vol/vol) with 0.1% ammonium acetate; solvent C, MeOH. To identify in vivo cleavage products, we used the gradient condition of 100% solvent B to 100% solvent C for 16 min, 100% solvent C for 19 min, 100% solvent C to 100% solvent A for 10 min, and 100% solvent A until 60 min or longer. The system was then returned to 100% solvent B at a flow rate of 0.8 ml/min. To identify the in vitro cleavage products, we used a gradient of 100% solvent B to 100% solvent C for 16 min, followed by 100% solvent C until 40 min, after which the system was returned to 100% solvent A at a flow rate of 0.8 ml/min. The gradients were extended for 2 to 3 min to resolve minor cleavage product peaks more clearly after complete conversion.

To analyze the kinetics results, we determined the reaction products by loading 30-μl extracts onto an HPLC system and typically eluting them under isocratic conditions with solvent system A at a flow rate of 1 ml/min. Mass fragmentation spectra were monitored using the positive ion modes in the mass range of m/z 100 to 800 on an Agilent 1200 LC-MS system equipped with an atmospheric pressure chemical ionization interface. For structural elucidation, the carotenoids and cleavage products were identified using a combination of HPLC retention times and UV/visible (UV/Vis) absorption and mass fragmentation spectra.

RESULTS

Cleavage of β-apo-8′-carotenal by NSC3.

β-Apo-8′-carotenal was first used as a substrate for the in vitro characterization of NSC3. As reported by Marasco et al. (17), when 5 μg purified NSC3 is incubated with β-apo-8′-carotenal at 30°C, the reaction mixture changes from reddish to yellowish, whereas the reddish color of the control reaction mixture incubated without NSC3 remains unchanged (Fig. 2A, inset). LC-MS analysis of the reaction revealed 2 major peaks, at 20 min (Fig. 2A, peak b) and 21 min (Fig. 2A, peaks c and d), and 1 minor peak, at 19 min (Fig. 2A, peak e). Peak b was identified as C20 trans-retinal based on the UV/Vis spectrum (λmax, 380 nm [Fig. 2B]), retention time (20 min), and molecular mass ([M + H]+ at m/z = 285.2 [Fig. 2C]), all of which were the same as those of authentic trans-retinal. The formation of trans-retinal indicated that NSC3 cleaved the C-15Inline graphicC-15′ double bond in β-apo-8′-carotenal, a result that conflicts with the report of NSC3 cleavage activity at the C-9Inline graphicC-10 double bond (17). Peaks c and d were identified as C22 cis- and trans-β-apo-14′-carotenals based on their retention times, UV/Vis spectra (Fig. 2B), and molecular masses ([M + H]+ at m/z = 311.4 [Fig. 2C]), indicating that NSC3 cleaved an additional, C-13′Inline graphicC-14′ double bond in β-apo-8′-carotenal. Minor peak e was identified as C18 β-apo-13-carotenone based on the UV/Vis spectrum and molecular mass ([M + H]+ at m/z = 259.1 [Fig. 2C]), proving that NSC3 cleaved the C-13Inline graphicC-14 double bond in β-apo-8′-carotenal as well. No reported apocarotenoid was detected as a cleavage product of the C-9Inline graphicC-10 double bond in β-apo-8′-carotenal. Therefore, NSC3 can cleave the C-13Inline graphicC-14, C-13′Inline graphicC-14′, and C-15Inline graphicC-15′ double bonds in β-apo-8′-carotenal in vitro (Fig. 1B), and multiple cleavage reactions can occur simultaneously or successively. In vitro assays with various incubation times have shown that NSC3 carries out simultaneous cleavage reactions rather than the successive cleavage of other CCDs (27).

Fig 2.

Fig 2

Cleavage of β-apo-8′-carotenal by NSC3. (A) High-performance liquid chromatography analysis of crude extracts obtained from NSC3 assay mixtures. The control reaction mixture (Con) was incubated without NSC3. (Inset) Changed color of the reaction mixture. (B and C) UV/Vis (B) and MS (C) spectra of identified peaks were recorded. Individual peaks were identified as follows: peak a, β-apo-8′-carotenal; peak b, trans-retinal; peaks c and d, cis- and trans-β-apo-14′-carotenal; peak e, β-apo-13-carotenone.

Steady-state kinetic analysis of NSC3.

Because no kinetic data on NSC3 comparable to those on NSC1 and NSC2 have been documented (17), enzymological characterization of NSC3 was performed using β-apo-8′-carotenal as a substrate. Optimal reaction conditions for NSC3 were 30°C and pH 7.0 based on the relative activity of NSC3 and the thermal stability of β-apo-8′-carotenal (approximately 5% of β-apo-8′-carotenal decomposes to unknown products in 30 min in the absence of NSC3). The Km and Vmax values of NSC3 on β-apo-8′-carotenal were 27.8 ± 3.4 μM and 0.29 ± 0.03 μM/min, respectively. The Km value of NSC3 on β-apo-8′-carotenal was similar to that of NSC2 (16), whereas kcat and kcat/Km values were 51.54 ± 5.41 s−1 and 1.85 ± 0.04 μM−1 s−1, respectively, and reflected fast catalytic activity on β-apo-8′-carotenal compared to that of other CCDs or apocarotenal cleavage oxygenases (12).

Cleavage of C30 carotenoids by NSC3 in vivo.

To investigate the cleavage reaction of NSC3 in vivo, we examined 6 C30 carotenoids with natural and nonnatural structures as the substrates in recombinant E. coli strains metabolically engineered to produce C30 carotenoids with various structures. Basically, to supply C30 carotenoids in vivo, plasmids with synthetic modules expressing C30 carotenoids with various structures (16, 23) were cotransformed into E. coli expressing NSC3. Acyclic C30 carotenoids (4,4′-diaponeurosporene, 4,4′-diapolycopene-4,4′-dial, 4,4′-diaponeurosporen-4′-al, and 4,4′-diaponeurosporen-4′-oic acid) (Table 2) were examined first in vivo. NSC3 cleaved 4,4′-diaponeurosporene at the C-13′Inline graphicC-14′ double bond, and the resulting cleavage product was identified as C17 apo-14′-diaponeurosporenal (Fig. 3A, peak b). NSC3 also cleaved the monoaldehyde carotenoid 4,4′-diaponeurosporen-4′-al at the C-9′Inline graphicC-10′ double bond and produced C22 apo-10′-diaponeurosporenal as a cleavage product (Fig. 3B, peak e). However, NSC3 did not cleave the dialdehyde carotenoid 4,4′-diapolycopene-4,4′-dial. The carboxylic carotenoid 4,4′-diaponeurosporen-4′-oic acid seemed to be cleaved at the C-9′Inline graphicC-10′ double bond by NSC3, because C22 apo-10′-diaponeurosporenal was detected as a cleavage product (Fig. 3C, peak e). Although C22 apo-10′-diaponeurosporenal may be a cleavage product of 4,4′-diaponeurosporen-4′-al (Fig. 3C, peak c), because the synthetic module that expressed 4,4′-diaponeurosporen-4′-oic acid also produced 4,4′-diaponeurosporen-4′-al as a minor product in E. coli (Table 2), the subsequent in vitro study confirmed that 4,4′-diaponeurosporen-4′-oic acid was clearly cleaved by NSC3 (see Fig. 5C).

Fig 3.

Fig 3

Cleavage of C30 carotenoids with different structures by NSC3 in vivo. From left to right, high-performance liquid chromatograms, cell pellets, crude extracts, UV/Vis spectra, and MS spectra of cleavage reaction products from Escherichia coli expressing synthetic modules and NSC3 together are shown. (A) pAC-MSA-NSA; (B) pAC-MSA-NSA-PSA; (C) pAC-MSA-NSA-PSA + pBBR-aldHSA; (D) pAC-MSA-NySA-YtBL; (E) pAC-MSA-NSA-PSA + pUCM-YtBL. The individual peaks were identified as follows: peak a, 4,4′-diaponeurosporene; peak b, apo-14′-diaponeurosporenal; peak c, 4,4′-diaponeurosporen-4′-al; peak d, 4,4′-diapolycopene-4,4′-dial; peak e, apo-10′-diaponeurosporenal; peak f, 4,4′-diaponeurosporen-4′-oic acid; peak g, 4,4′-diapotorulene; peak h, apo-14′-diapotorulenal; peak i, 4,4′-diapotorulen-4′-al; peak j, apo-10′-diapotorulenal.

Fig 5.

Fig 5

Cleavage of purified C30 and C40 carotenoids with different structures by NSC3 in vitro. High-performance liquid chromatograms of reaction products from an in vitro assay of NSC3 cleavage of purified carotenoid structures are shown. (A) 4,4′-Diaponeurosporene (peak a); (B) 4,4′-diaponeurosporen-4′-al (peak b); (C) 4,4′-diaponeurosporen-4′-oic acid (peak c); (D) 4,4′-diapotorulene (peak d); (E) 4,4′-diapotorulen-4′-al (peak e); (F) torulene (peak f). The cleavage peaks were identified as follows: a-1, apo-14′-diaponeurosporenal (λmax, 373 nm; M+ at m/z = 244.18); a-2, apo-13′-diaponeurosporenone (λmax, 370 nm; M+ at m/z = 190.13); b-1, apo-10′-diaponeurosporenal (λmax, 422 nm; M+ at m/z = 310.23); b-2, apo-14′-diaponeurosporenal; c-1, apo-10′-diaponeurosporenal; d-1, apo-14′-diapotorulenal (λmax, 355 nm; M+ at m/z = 244.18); e-1, apo-10′-diapotorulenal (λmax, 408 nm; M+ at m/z = 310.23); f-1, retinal (λmax, 380 nm; M+ at m/z = 284.21).

Next, 2 nonnatural monocyclic C30 carotenoids (4,4′-diapotorulene and 4,4′-diapotorulen-4′-al) were examined in vivo. These carotenoids have not been found in nature and were synthesized in E. coli using 2 enzymes generated via directed evolution: a mutant diapophytoene desaturase and a mutant lycopene cyclase (unpublished data). NSC3 cleaved the monocyclic carotenoid 4,4′-diapotorulene at its C-13′Inline graphicC-14′ double bond and the monocyclic aldehyde carotenoid 4,4′-diapotorulen-4′-al at its C-9′Inline graphicC-10′ double bond. The cleavage products were identified as C17 apo-14′-diapotorulenal (Fig. 3D, peak h) and C22 apo-10′-diapotorulenal (Fig. 3E, peak j) based on their retention times, UV/Vis spectra, and molecular masses ([M + H]+ = 245.2 and 311.2, respectively).

Cleavage of C40 carotenoids by NSC3 in vivo.

For further investigation of the cleavage reaction of NSC3 in vivo, 5 C40 carotenoids with different structures were examined as substrates in E. coli. In a manner similar to that for supplying C30 carotenoids in vivo, plasmids with synthetic modules expressing the C40 carotenoids were cotransformed into E. coli expressing NSC3. First, 2 acyclic C40 carotenoids (lycopene and 3,4,3′,4′-tetradehydrolycopene [Table 2]) were examined in vivo. While NSC3 did not cleave lycopene (Fig. 4A), it cleaved a fully conjugated carotenoid, 3,4,3′,4′-tetradehydrolycopene, to generate cleavage products (Fig. 4B, peaks b and c). Although highly resolved MS spectra of the cleavage products could not be obtained because of the small quantities present, they were highly likely to be the cleavage products of 3,4,3′,4′-tetradehydrolycopene, since their UV/Vis spectra were similar to those of apocarotenals. Next, 3 cyclic C40 carotenoids (torulene, β-carotene, and zeaxanthin) were examined in vivo. NSC3 cleaved the monocyclic and fully conjugated carotenoid torulene (Fig. 4C, peaks e and f), and one of the cleavage products was determined to be C22 trans-retinal, which indicated that NSC3 cleaved the C-15Inline graphicC-15′ bond in torulene. However, NSC3 did not cleave the bicyclic carotenoids β-carotene and zeaxanthin (Fig. 4D and E).

Fig 4.

Fig 4

Cleavage of C40 carotenoids with different structures by NSC3 in vivo. From left to right, high-performance liquid chromatograms, cell pellets, crude extracts, and UV/Vis spectra of cleavage reaction products from E. coli coexpressing synthetic gene modules and NSC3 are shown. (A) pAC-EPA-BPA-IPA; (B) pAC-E-B-I14; (C) pAC-E-B-I14-Y2; (D) pAC-EPA-BPA-IPA-YPA; (E) pAC-EPA-BPA-IPA-YPA-ZPA. The peaks were identified as follows: peak a, lycopene; peaks b, c, e, and f, unidentified cleavage products; peak d, torulene; peak g, β-carotene; peak h, zeaxanthin.

Cleavage of C30 and C40 carotenoids by NSC3 in vitro.

After several C30 and C40 carotenoids were examined as in vivo substrates of NSC3, the in vitro cleavage reaction of NSC3 was investigated using 5 purified C30 carotenoids (4,4′-diaponeurosporene, 4,4′-diaponeurosporen-4′-al, 4,4′-diaponeurosporen-4′-oic acid, 4,4′-diapotorulene, and 4,4′-diapotorulen-4′-al) and 1 C40 carotenoid (torulene). As observed in vivo, the main cleavage product of 4,4′-diaponeurosporene was C17 apo-14′-diaponeurosporenal (Fig. 5A, peak a-1). Notably, an additional cleavage product (C13 apo-13′-diaponeurosporenone), which was not detected in vivo, was also observed (Fig. 5A, peak a-2). These results support the hypothesis that NSC3 cleaves 4,4′-diaponeurosporene at the C-13′Inline graphicC-14′ double bond. Similarly, the cleavage products of 4,4′-diaponeurosporen-4′-al were identified as C22 apo-10′-diaponeurosporenal (Fig. 5B, peak b-1), which was also observed in vivo, and C17 apo-14′-diaponeurosporenal (Fig. 5B, peak b-2), which was absent in vivo. In contrast to the single cleavage of 4,4′-diaponeurosporene at the C-13′Inline graphicC-14′ double bond, 4,4′-diaponeurosporen-4′-al was cleaved at both the C-9′Inline graphicC-10′ and C-13′Inline graphicC-14′ double bonds. However, as observed in vivo, only C22 apo-10′-diaponeurosporenal (Fig. 5C, peak c-1) was detected as a cleavage product of 4,4′-diaponeurosporen-4′-oic acid at the C-9′Inline graphicC-10′ double bond. Similarly, the monocyclic carotenoid 4,4′-diapotorulene was cleaved in vitro at the C-13′Inline graphicC-14′ double bond, just as it was in vivo, resulting in C17 apo-14′-diapotorulenal (Fig. 5D, peak d-1). The monocyclic carotenoid 4,4′-diapotorulen-4′-al was also cleaved at the C-9′Inline graphicC-10′ double bond in vitro, and C22 apo-10′-diapotorulenal, which was observed in vivo, was identified as a cleavage product (Fig. 5E, peak e-1). The longer monocyclic carotenoid torulene was also cleaved at the C-15Inline graphicC-15′ double bond, generating C20 trans-retinal (Fig. 5F, peak f-1), as observed in vivo.

DISCUSSION

CCDs from various sources have been cloned and identified functionally to elucidate their physiological roles in plants and animals (27). Nostoc sp. PCC 7120 is a well-known cyanobacterium in which 3 CCDs have been identified thus far: NSC1, NSC2, and NSC3. Enzymatic knowledge of NSC1 and NSC2 is thorough, but the enzymatic properties of NSC3 remain unclear.

We observed that NSC3 cleaves β-apo-8′-carotenal at 3 specific double bond positions in vitro—C-15Inline graphicC-15′, C-13′Inline graphicC-14′, and C-13Inline graphicC-14—and has relatively broad preferences for natural or nonnatural carotenoid structures in vivo and in vitro. NSC1 catalyzes the cleavage of C-9Inline graphicC-10 and C-9′Inline graphicC-10′ bonds in bicyclic carotenoids and the cleavage of C-9Inline graphicC-10 and C-7′Inline graphicC-8′ bonds in monocyclic carotenoids (15, 17). NSC2 cleaves β-apo-8′-carotenal or β-carotene at their C-15Inline graphicC-15′ bonds, as well as carotene backbones with chain lengths of C27 to C30, carotene backbones of hydroxylated β-rings, and carotene backbones of substituted aldehyde-to-hydroxyl groups at the C-15Inline graphicC-15′ double bond (15). Therefore, NSC1, NSC2, and NSC3 in Nostoc sp. PCC 7120 may function cooperatively in response to cellular conditions, because they have relatively different substrate preferences and cleavage reactions.

The observed cleavage pattern of NSC3 is unique because the cleavage of C-13′Inline graphicC-14′ double bonds in carotenoids has been observed mainly in animal intestinal enzyme extracts with β-apo-8′-carotenal or β-carotene as the substrate (28, 29). Although the cellular metabolism of the C-13′Inline graphicC-14′ cleavage product β-apo-14′-carotenal has not been documented in Nostoc sp. PCC 7120, NSC1 or NSC2 may be involved in the oxidative cleavage reaction of β-apo-14′-carotenal to generate retinal or other signaling compounds, such as abscisic acid or trisporoids in Blakeslea trispora (30). In addition, the cleavage of C-13Inline graphicC-14 double bonds has been reported only for the CCDs of Arabidopsis thaliana, Oryza sativa, Pisum sativum, Novosphingobium aromaticivorans, and M. tuberculosis (9, 11, 13, 31). In particular, the carotenoid cleavage oxygenase of M. tuberculosis (MtCCO) cleaves C-13Inline graphicC-14 and C-13′Inline graphicC-14′ double bonds as well as C-15Inline graphicC-15′ double bonds in various bicyclic carotenoids, including β-carotene or apocarotenals (13). However, although NSC3, like MtCCO, cleaves the C-13Inline graphicC-14, C-13′Inline graphicC-14′, and C-15Inline graphicC-15′ double bonds in β-apo-8′-carotenal, it cannot cleave bicyclic carotenoids, such as β-carotene. Structural studies will elucidate the differences in substrate preference between MtCCO and NSC3.

NSC3 has a relatively broad preference for carotenoid structures. It can cleave both acyclic C30 carotenoids (4,4′-diaponeurosporene, 4,4′-diaponeurosporen-4′-al, and 4,4′-diaponeurosporen-4′-oic acid) and monocyclic C30 carotenoids (4,4′-diapotorulene and 4,4′-diapotorulen-4′-al) in vivo (Fig. 6). The in vitro assay using purified C30 carotenoids demonstrated the same unique NSC3 activities observed in vivo. NSC3 also cleaves both the acyclic fully conjugated C40 carotenoid 3,4,3′,4′-tetradehydrolycopene and the monocyclic fully conjugated C40 carotenoid torulene in vivo and in vitro (Fig. 6). In the latter case, the C-15Inline graphicC-15′ cleavage product retinal was generated from torulene by a direct cleavage reaction of NCS3 at the C-15Inline graphicC15′ double bond. However, NCS3 cannot accept other C40 carotenoids, such as lycopene and β-carotene, which have no fully conjugated double bonds in at least one end of their backbones (Fig. 6). This NSC3 substrate preference may be explained by the fact that the fully conjugated double bonds of a carotene backbone would aid in the entry and binding of the carotenoid into an active pocket (32, 33).

Fig 6.

Fig 6

Structures of C30 and C40 carotenoids that serve as substrates for NSC3 and their cleavage products. The cleavage sites in each carotenoid substrate are indicated by shaded ellipses. ND, not detected; ?, high possibility but no mass data.

The unique cleavage activity of NSC3 can be used to produce apocarotenals of biotechnological importance. Recently, apocarotenals and apocarotendials have attracted increasing interest owing to their anticancer effects (34, 35). Therefore, the cleavage products of C30 carotenoids, such as C17 β-apo-14′-diaponeurosporenal, reported in this study may be bioactive compound candidates in, for example, electrophile/antioxidant response element transcription systems (34). In addition to these biological activities, β-apo-14′-carotenal has been discovered to inhibit the activation of peroxisome proliferator-activated receptors and retinoid X receptor in adipocytes (35).

We conclusively characterized the activity and substrate preferences of NSC3 in vitro and in vivo with natural and nonnatural carotenoid structures generated with synthetic carotenoid modules in E. coli. NSC3 displays unique cleavage activity with β-apo-8′-carotenal in vitro, providing new insight into the cleavage reactions of CCDs. We also applied synthetic biology to an investigation of the cleavage reactions and substrate preferences of NSC3 in vivo and in vitro. The modular expression of carotenoid pathway enzymes in E. coli provides NSC3 with natural and nonnatural carotenoid structures in vivo and in vitro. Consequently, we found that NSC3 uses natural and nonnatural C30 carotenoids (not apocarotenoids) as substrates to generate structurally novel cleavage products. These novel apocarotenal structures may be bioactive compounds of biotechnological significance. In addition to the potential biotechnological applications of their novel cleavage products, carotenoids with natural or nonnatural structures can also provide information valuable for understanding the cleavage reactions and substrate preferences of other CCDs in vivo and in vitro.

ACKNOWLEDGMENTS

This study was supported by National Research Foundation of Korea grants, funded by the Korean Government (2012M1A2A2026562), and by the Intelligent Synthetic Biology Center of the Global Frontier Project, funded by the Ministry of Education, Science, and Technology (2011-0031968).

Footnotes

Published ahead of print 22 March 2013

REFERENCES

  • 1. Cazzonelli CI. 2011. Carotenoids in nature: insights from plants and beyond. Funct. Plant Biol. 38: 833–847 [DOI] [PubMed] [Google Scholar]
  • 2. Liu CI, Liu GY, Song Y, Yin F, Hensler ME, Jeng WY, Nizet V, Wang AHJ, Oldfield E. 2008. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319: 1391–1394 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Johnson ET, Schmidt-Dannert C. 2008. Light-energy conversion in engineered microorganisms. Trends Biotechnol. 26: 682–689 [DOI] [PubMed] [Google Scholar]
  • 4. Holt NE, Zigmantas D, Valkunas L, Li XP, Niyogi KK, Fleming GR. 2005. Carotenoid cation formation and the regulation of photosynthetic light harvesting. Science 307: 433–436 [DOI] [PubMed] [Google Scholar]
  • 5. Lee PC, Schmidt-Dannert C. 2003. Metabolic engineering towards biotechnological production of carotenoids in microorganisms. Appl. Microbiol. Biotechnol. 60: 1–11 [DOI] [PubMed] [Google Scholar]
  • 6. Sharoni Y, Linnewiel-Hermoni K, Khanin M, Salman H, Veprik A, Danilenko M, Levy J. 2012. Carotenoids and apocarotenoids in cellular signaling related to cancer: a review. Mol. Nutr. Food Res. 56: 259–269 [DOI] [PubMed] [Google Scholar]
  • 7. Walter MH, Strack D. 2011. Carotenoids and their cleavage products: biosynthesis and functions. Nat. Prod. Rep. 28: 663–692 [DOI] [PubMed] [Google Scholar]
  • 8. Alder A, Jamil M, Marzorati M, Bruno M, Vermathen M, Bigler P, Ghisla S, Bouwmeester H, Beyer P, Al-Babili S. 2012. The path from β-carotene to carlactone, a strigolactone-like plant hormone. Science 335: 1348–1351 [DOI] [PubMed] [Google Scholar]
  • 9. Alder A, Holdermann I, Beyer P, Al-Babili S. 2008. Carotenoid oxygenases involved in plant branching catalyse a highly specific conserved apocarotenoid cleavage reaction. Biochem. J. 416: 289–296 [DOI] [PubMed] [Google Scholar]
  • 10. Nambara E, Marion-Poll A. 2005. Abscisic acid biosynthesis and catabolism. Annu. Rev. Plant Biol. 56: 165–185 [DOI] [PubMed] [Google Scholar]
  • 11. Kim YS, Seo ES, Oh DK. 2012. Characterization of an apo-carotenoid 13,14-dioxygenase from Novosphingobium aromaticivorans that converts β-apo-8′-carotenal to β-apo-13-carotenone. Biotechnol. Lett. 34: 1851–1856 [DOI] [PubMed] [Google Scholar]
  • 12. Hoffmann J, Bóna-Lovász J, Beuttler H, Altenbuchner J. 2012. In vivo and in vitro studies on the carotenoid cleavage oxygenases from Sphingopyxis alaskensis RB2256 and Plesiocystis pacifica SIR-1 revealed their substrate specificities and non-retinal-forming cleavage activities. FEBS J. 279: 3911–3924 [DOI] [PubMed] [Google Scholar]
  • 13. Scherzinger D, Scheffer E, Bär C, Ernst H, Al-Babili S. 2010. The Mycobacterium tuberculosis ORF Rv0654 encodes a carotenoid oxygenase mediating central and excentric cleavage of conventional and aromatic carotenoids. FEBS J. 277: 4662–4673 [DOI] [PubMed] [Google Scholar]
  • 14. Jung KH, Trivedi VD, Spudich JL. 2003. Demonstration of a sensory rhodopsin in eubacteria. Mol. Microbiol. 47: 1513–1522 [DOI] [PubMed] [Google Scholar]
  • 15. Scherzinger D, Al-Babili S. 2008. In vitro characterization of a carotenoid cleavage dioxygenase from Nostoc sp. PCC 7120 reveals a novel cleavage pattern, cytosolic localization and induction by highlight. Mol. Microbiol. 69: 231–244 [DOI] [PubMed] [Google Scholar]
  • 16. Scherzinger D, Ruch S, Kloer DP, Wilde A, Al-Babili S. 2006. Retinal is formed from apo-carotenoids in Nostoc sp. PCC7120: in vitro characterization of an apo-carotenoid oxygenase. Biochem. J. 398: 361–369 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Marasco EK, Vay K, Schmidt-Dannert C. 2006. Identification of carotenoid cleavage dioxygenases from Nostoc sp. PCC 7120 with different cleavage activities. J. Biol. Chem. 281: 31583–31593 [DOI] [PubMed] [Google Scholar]
  • 18. Yadav VG, Mey MD, Lim CG, Ajikumar PK, Stephanopoulos G. 2012. The future of metabolic engineering and synthetic biology: Towards a systematic practice. Metab. Eng. 14: 233–241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Kim SH, Lee PC. 2012. Functional expression and extension of staphylococcal staphyloxanthin biosynthetic pathway in Escherichia coli. J. Biol. Chem. 287: 21575–21583 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Horinouchi S. 2009. Combinatorial biosynthesis of plant medicinal polyketides by microorganisms. Curr. Opin. Chem. Biol. 13: 197–204 [DOI] [PubMed] [Google Scholar]
  • 21. Lee PC, Holtzapple E, Schmidt-Dannert C. 2010. Novel activity of Rhodobacter sphaeroides spheroidene monooxygenase CrtA expressed in Escherichia coli. Appl. Environ. Microbiol. 76: 7328–7331 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Kim SH, Park YH, Schmidt-Dannert C, Lee PC. 2010. Redesign, reconstruction, and directed extension of the Brevibacterium linens C40 carotenoid pathway in Escherichia coli. Appl. Environ. Microbiol. 76: 5199–5206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, Roop RM, II, Peterson KM. 1995. Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166: 175–176 [DOI] [PubMed] [Google Scholar]
  • 24. Song GH, Kim SH, Choi BH, Han SJ, Lee PC. 2013. Heterologous carotenoid-biosynthetic enzymes: functional complementation and effects on carotenoid profiles in Escherichia coli. Appl. Environ. Microbiol. 79: 610–618 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Schmidt-Dannert C, Umeno D, Arnold FH. 2000. Molecular breeding of carotenoid biosynthetic pathways. Nat. Biotechnol. 18: 750–753 [DOI] [PubMed] [Google Scholar]
  • 26. Lee PC, Momen AZR, Mijts BN, Schmidt-Dannert C. 2003. Biosynthesis of structurally novel carotenoids in Escherichia coli. Chem. Biol. 10: 453–462 [DOI] [PubMed] [Google Scholar]
  • 27. Auldridge ME, McCarty DR, Klee HJ. 2006. Plant carotenoid cleavage oxygenases and their apocarotenoid products. Curr. Opin. Plant Biol. 9: 315–321 [DOI] [PubMed] [Google Scholar]
  • 28. Liu C, Wang XD, Russell RM. 1997. Biosynthesis of retinoic acid from β-apo-14′-carotenal in ferret in vivo. J. Nutr. Biochem. 8: 652–657 [Google Scholar]
  • 29. Tang GW, Wang XD, Russell RM, Krinsky NI. 1991. Characterization of β-apo-13-carotenone and β-apo-14′-carotenal as enzymatic products of the excentric cleavage of β-carotene. Biochemistry 30: 9829–9834 [DOI] [PubMed] [Google Scholar]
  • 30. Barrero AF, Herrador MM, Arteaga P, Gil J, González JA, Alcalde E, Cerdá-Olmedo E. 2011. New apocarotenoids and β-carotene cleavage in Blakeslea trispora. Org. Biomol. Chem. 9: 7190–7195 [DOI] [PubMed] [Google Scholar]
  • 31. Schwartz SH, Qin X, Loewen MC. 2004. The biochemical characterization of two carotenoid cleavage enzymes from Arabidopsis indicates that a carotenoid-derived compound inhibits lateral branching. J. Biol. Chem. 279: 46940–46945 [DOI] [PubMed] [Google Scholar]
  • 32. Kim YS, Park CS, Oh DK. 2010. Hydrophobicity of residue 108 specifically affects the affinity of human β-carotene 15,15′-monooxygenase for substrates with two ionone rings. Biotechnol. Lett. 32: 847–853 [DOI] [PubMed] [Google Scholar]
  • 33. Kloer DP, Ruch S, Al-Babili S, Beyer P, Schulz GE. 2005. The structure of a retinal-forming carotenoid oxygenase. Science 308: 267–269 [DOI] [PubMed] [Google Scholar]
  • 34. Linnewiel K, Ernst H, Caris-Veyrat C, Ben-Dor A, Kampf A, Salman H, Danilenko M, Levy J, Sharoni Y. 2009. Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription system. Free Radic. Biol. Med. 47: 659–667 [DOI] [PubMed] [Google Scholar]
  • 35. Ziouzenkova O, Orasanu G, Sukhova G, Lau E, Berger JP, Tang G, Krinsky NI, Dolnikowski GG, Plutzky J. 2007. Asymmetric cleavage of β-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses. Mol. Endocrinol. 21: 77–88 [DOI] [PubMed] [Google Scholar]

Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES